ADVM - Rasio utang marang kapitalisasi buku adverum.com

Adverum Biotechnologies (ADVM) relies on investor capital as its retinal therapy development remains in the clinical phase. The debt-to-market cap ratio on the GURU.Markets daily chart reflects the dynamics of the debt burden, where 0.00 is the current value of the indicator. The company aims to replace AMD injections with the AAV.7m8 vector, although cash flows remain episodic and unpredictable.

ADVM (Adverum Biotechnologies, Inc.) riwayat Utang marang nilai buku saka 04.07.2022 nganti 20.12.2025

Rincian metrik lan analitis perusahaan adverum.com (ADVM)

- rega lan prakiraan konsensus rega:

Rega saham Adverum Biotechnologies, Inc.|ADVM - Prakiraan konsensus analis

- data kapitalisasi pasar:

Nilai pasar Adverum Biotechnologies, Inc.|ADVM - Nilai Dipunlarasaken Utang lan Kas

- data kapitalisasi buku:

Aset Bersih saben Siji Saham Adverum Biotechnologies|ADVM - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku adverum.com|ADVM - Total Aset Perusahaan

- data utang lan likuiditas:

Rasio Total Utang marang Ekuitas Adverum Biotechnologies|ADVM - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal Adverum Biotechnologies, Inc.|ADVM - Utang kumulatif perusahaan|Utang marang nilai buku Adverum Biotechnologies, Inc.|ADVM - Utang jangka dawa|Utang jangka cendhak perusahaan Adverum Biotechnologies

Analisis kabeh metrik perusahaan:Adverum - ADVM

The debt-to-equity ratio determines the financial stability of a business across shifting economic cycles. A decrease in this metric minimizes the risk of default during a recession, yet it may signal an underutilization of growth leverage. Analyzing the current debt-to-book capitalization ratio allows for the separation of market noise from actual solvency. For Adverum Biotechnologies (ADVM), such stability supports the implementation of energy-saving systems and compliance with environmental standards for biomaterial disposal.

Pesaing Adverum Biotechnologies